(Q38937332)

7 September 2017

title

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer (English)

1 reference

7 September 2017

1 reference

Jeong-Won Lee

1

1 reference

7 September 2017

Ji-Yoon Ryu

2

1 reference

7 September 2017

Gun Yoon

3

1 reference

7 September 2017

Hye-Kyung Jeon

4

1 reference

7 September 2017

Young-Jae Cho

5

1 reference

7 September 2017

Jung-Joo Choi

6

1 reference

7 September 2017

Sang Yong Song

7

1 reference

7 September 2017

In-Gu Do

8

1 reference

7 September 2017

Yoo-Young Lee

9

1 reference

7 September 2017

Tae-Joong Kim

10

1 reference

7 September 2017

Chel Hun Choi

11

1 reference

7 September 2017

Byoung-Gie Kim

12

1 reference

7 September 2017

Duk-Soo Bae

13

1 reference

7 September 2017

language of work or name

English

0 references

publication date

8 December 2014

1 reference

International Journal of Cancer

7 September 2017

published in

1 reference

7 September 2017

volume

137

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

221-229

1 reference

Early events in the pathogenesis of epithelial ovarian cancer

7 September 2017

cites work

1 reference

Roles of bioactive sphingolipids in cancer biology and therapeutics

21 January 2018

1 reference

Inhibitors of the sphingosine kinase pathway as potential therapeutics.

21 January 2018

1 reference

Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting

21 January 2018

1 reference

Sphingolipids as modulators of cancer cell death: potential therapeutic targets

21 January 2018

1 reference

Sphingosine 1-phosphate and cancer

21 January 2018

1 reference

Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules

21 January 2018

1 reference

Molecular targets of FTY720 (fingolimod).

21 January 2018

1 reference

Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug

21 January 2018

1 reference

Evaluating cell lines as tumour models by comparison of genomic profiles

21 January 2018

1 reference

Tumor suppressive effects of bromodomain-containing protein 7 (BRD7) in epithelial ovarian carcinoma.

21 January 2018

1 reference

EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma

21 January 2018

1 reference

Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer

21 January 2018

1 reference

miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways

21 January 2018

1 reference

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

21 January 2018

1 reference

Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer

21 January 2018

1 reference

Sphingosine kinase 1 and cancer: a systematic review and meta-analysis

21 January 2018

1 reference

Sphingosine kinase mediates resistance to the synthetic retinoid N-(4-hydroxyphenyl)retinamide in human ovarian cancer cells.

21 January 2018

1 reference

Sphingosine kinase-1 inhibition sensitizes curcumin-induced growth inhibition and apoptosis in ovarian cancer cells

21 January 2018

1 reference

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform

21 January 2018

1 reference

Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis

21 January 2018

1 reference

Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines

21 January 2018

1 reference

Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin

21 January 2018

1 reference

SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism

21 January 2018

1 reference

"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets

21 January 2018

1 reference

Oral fingolimod (FTY720) for relapsing multiple sclerosis

21 January 2018

1 reference

Sphingosine kinase isoforms regulate oxaliplatin sensitivity of human colon cancer cells through ceramide accumulation and Akt activation.

21 January 2018

1 reference

Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.

21 January 2018

1 reference

Synthetic retinoid fenretinide in breast cancer chemoprevention

21 January 2018

1 reference

FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy.

21 January 2018

1 reference

FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: is FTY720 the next autophagy-blocking agent in lymphoma treatment?

21 January 2018

1 reference

Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.47.208

Identifiers

DOI

10.1002/IJC.29362

1 reference

7 September 2017

1 reference